OctobidOCTOBIDPublic Tender Gazette
octobid.net

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

synopsis monitored from grants-gov.

Buyer / agency
National Institutes of Health
Notice type
synopsis
Solicitation number
PA-27-101
Posted
May 28, 2026
Response deadline
April 5, 2029
Location
US
Estimated value
Not published by the source
NAICS
Not supplied
Source
grants-gov

Summary

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.

Start free — no credit cardMore live tenders

Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.